in page functions
Total population (2018) 1,393,623,301
Birth cohort (2018) 15,710,492
Surviving Infants (surviving to 1 year per year, 2018) 15,564,073
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 9/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 11/1000
Gross Nation Income (per capita US$, 2015) 7,930
No. of districts/territories (2017) 2,851

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for China

Type of support


2001-2023 (US$)
(23 May 2019)


2001-2023 (US$)
(23 May 2019)


2000-2019 (US$)
(23 May 2019)

% Disbursed

(23 May 2019)
2002 2003 2004 2005 2006
Total $38,679,133 $38,679,133 $38,679,133
HepB mono (NVS) $21,952,552 $21,952,552 $21,952,552 100%
Injection safety support (INS) $15,926,581 $15,926,581 $15,926,581 100%
Vaccine Introduction Grant (VIG) $800,000 $800,000 $800,000 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

China DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence

DTP3 - Official country estimates (2017) 99%
M:F sex ratio at birth (2018) 1.15
% districts achieving > 80% DTP3 coverage (2017) 104%
% districts achieving < 50% DTP3 coverage (2017) 0%
MCV WHO/UNICEF estimates (2017) 99%

Breakdown of support

Non-vaccine support Vaccine support
43% 57%
$16,726,581 $21,952,552

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to China

11 June 2019

EPI LAMP Yaounde

New management training for immunisation leaders kicks-off at the University of Yaounde

National teams from six Gavi-supported countries will attend the first forum of the nine-month programme.

27 September 2018

Anuradha Linkedin hepb

Why hepatitis B vaccination should be Plan A in the fight against liver cancer

Gavi Deputy CEO Anuradha Gupta highlights the major role that vaccines can play in the response to non-communicable diseases.

29 June 2017

Li Xiaopeng and Seth Berkley

Gavi welcomes US$ 1.5 million contribution from China Merchants Group

The pledge will support Gavi’s mission to immunise 300 million of the world’s poorest children by 2020.

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

close icon

modal window here